Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Urovant Sciences launches international phase III COURAGE study of vibegron

March 28, 2019

New mutations in NPHP3 and NEK8 are associated with renal-hepatic-pancreatic dysplasia

March 26, 2019

Positive topline results presented from pivotal phase III EMPOWUR study of vibegron

March 20, 2019

Arch Biopartners receives approval for phase I study of Metablok in Australia

March 20, 2019

Clinical data reported for litoxetine in mixed urinary incontinence

March 19, 2019

Veverimer phase III results for metabolic acidosis associated with chronic kidney disease

March 15, 2019

Dicerna enrolling in phase II study of DCR-PHXC for primary hyperoxaluria

March 11, 2019

Eli Lilly and Company synthesizes PDE1 inhibitors

March 4, 2019

Lilly synthesizes new phosphodiesterase PDE1 inhibitors

Feb. 26, 2019

Imarikiren improves albuminuria in patients with type 2 diabetes

Feb. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...